Andy’s background is in PRO research, with considerable experience in patient preferences/utilities. He has held senior positions at ICON plc, Oxford Outcomes and United BioSource Corporation in London. He has also held research posts at several universities within the UK and supervised several students at masters and doctoral level. He teaches each year at the University of York on a residential course concerned with health outcomes measurement and he holds a research affiliation with University of Bath, UK. His research work is focused on developing and testing assessments of health-related quality of life with a particular focus on utility measurement. He has undertaken work to support HTA or regulatory submissions in a broad range of therapeutic areas including oncology, rare diseases, autoimmune disease as well as work on medical devices. Apart from that he is an active member of ISPOR, where he teaches on their short course programs in the EU and US. He is also a co-editor of Value in Health, sits on the international advisory board for the journal Quality of Life Research and is active in the EuroQol Group where he sits on the Executive Committee. He has chaired many international advisory boards designed to explore reimbursement and market access issues.